Transforming Breast Cancer Diagnosis. BioEclosion’s breakthrough in biosensing technology In an exciting development for the field of medical diagnostics, our latest product, the specialized cartridge for biosensing applications, has been featured in a pioneering study published in Biosensors and Bioelectronics. This study, titled “Peptide-based biosensing approaches for targeting breast cancer-derived exosomes”, marks a significant milestone in …
by systems_gfpjfose 
At Bioeclosion, the last month of 2024 has been truly inspiring! As a spin-off from UAB, Bioeclosion participated in the annual ‘Fòrum Arquímedes’ event, which brought together all spin-off companies from the university at the ‘Casa de la Convalescència’ in Barcelona, Spain, on December 10th. It was a networking event aimed at building community and …
by systems_gfpjfose We are thrilled to announce that BioEclosion will be participating in 4 Years From Now (4YFN), the premier event for startups, held under the umbrella of the Mobile World Congress (MWC) Barcelona from March 3-6, 2025. As a spin-off of the Universitat Autònoma de Barcelona (UAB), BioEclosion is proud to be among the pioneering companies featured at the UAB stand (8.1C42). At …
by systems_gfpjfose 
Dr. Jofre Ferrer-Dalmau, CEO of BioEclosion, has recently participated in the last edition of BioSpain Congress, organized in Barcelona, 26-28th of September 2023.
by systems_gfpjfose 
What a week at 4 Years From Now (4YFN) 2025 Congress held within the Mobile World Congress (MWC) in Barcelona BioEclosion proudly presented its prototype of next-generation biosensor-based diagnostic device at the UAB stand (8.1C42) to 4YFN-MWC attendees. After 4 busy days presenting our patented technology, we are even more commited and motivated to fulfill our mission: enhance early disease detection and …
by systems_gfpjfose Input your search keywords and press Enter.
